Michael Thomas Heffernan, Director at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 558,661 shares at $22.69 ($12.2M) on 2020-01-21, disclosed to the SEC on 2020-01-22.
Open-market sale of $12.2M COLL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.56 | 787 | $17K | 0.1% |
| 2 | $21.84 | 262,587 | $5.7M | 46.9% |
| 3 | $21.84 | 262,587 | $5.7M | 46.9% |
| 4 | $22.69 | 32,700 | $742K | 6.1% |
| Total | $21.89 avg | 558,661 | $12.2M | 100% |
| Filing → |
| COLL | SELL | 2022-12-14 | $8.4M | — | Filing → |
| COLL | SELL | 2021-03-17 | $2.5M | — | Filing → |
| COLL | SELL | 2020-08-12 | $500K | — | Filing → |